Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4171 AL 4185

ATP13A2 Loss of Function-Driven Polyamine Dysregulation Induces SAM Depletion and Epigenetic Astrocyte Toxicity

Coccia E, Parfitt GM, Ijaz S, Sati A, Gesner J, Arevalo AP, Strong J, Bright A, Sohail S, Meimoun T, Ahfeldt T, Vangheluwe P, Blanchard J.

bioRxiv [Preprint]. 2026 Apr 6:2026.04.02.716164. doi: 10.64898/2026.04.02.716164.

Efficacy of cognitive behavioral therapy combined with oral motor training for dysarthria in patients with Parkinson's disease

Lan J, Li W, Ding M, Qi J, Wang Y.

Clin Neurol Neurosurg. 2026 Aug;267:109469. doi: 10.1016/j.clineuro.2026.109469. Epub 2026 May 8.

Cell vulnerability within the sublaterodorsal tegmental nucleus underlies REM sleep behaviour disorder in prodromal α-synucleinopathy

Luke R, Yoo HS, McKenna D, Bevan A, Durso C, Dugan BJ, Liang Y, Amanirad B, Steltz JA, Zhang B, Yearwood A, Lourie J, Lee PH, Fraigne JJ, Peever J, Luk KC.

bioRxiv [Preprint]. 2026 May 1:2026.04.28.719687. doi: 10.64898/2026.04.28.719687.

[Chronic diarrhea in Parkinson's disease during Levodopa therapy]

Macht A, Cathomas G, Bauer E, Essig M, Flückiger M.

Praxis (Bern 1994). 2026 May;115(5):145-148. doi: 10.23785/PRAXIS.2026.05.006.

WDR44 drives de novo α-synuclein aggregation at the lysosomal membrane and promotes neuronal dysfunction in Parkinson's Disease

Teixeira M, Sheta R, Bérard M, Insinna C, Mahul-Mellier AL, Delmas CVL, Lépinay E, Idi W, Ricard A, Del Cid-Pellitero E, Trabolsi C, Gobeil S, Canron MH, Bézard E, Rajput A, Cicchetti F, Parent M, Fon EA, Ramalingam N, Dettmer U, Calon F, Westlake C, Lashuel HA, Oueslati A.

bioRxiv [Preprint]. 2026 Apr 7:2026.04.03.716340. doi: 10.64898/2026.04.03.716340.

Nicotine protects astrocytes expressing alpha-synuclein against aminochrome cytotoxicity: Implications for Parkinson's disease

Soares ÉN, Bartolomeo CS, Nicoliche T, Lima IS, de Oliveira LMG, Ferrolho GJ, Oliveira RB, Stilhano RS, Costa SL, Tizabi Y, Ureshino RP, da Silva VDA.

Res Sq [Preprint]. 2026 May 9:rs.3.rs-9410157. doi: 10.21203/rs.3.rs-9410157/v1.

Exploring the role of gut microbiota in potential mechanism of ketogenic diet in alleviating Parkinson's disease symptoms

Luo XM, Luo J, Zhang Q, Zeng LY, Liu B, Chi CL.

Front Neurosci. 2026 Jan 23;20:1678894. doi: 10.3389/fnins.2026.1678894. eCollection 2026.

Case Report: CAR-T therapy for relapsed diffuse large B-cell lymphoma in a patient with pre-existing Parkinson's disease-unfolding clinical challenges

Ibraheem A, Vincentelli H, Kuhnl A, Kumar EA, Davila AM, Patten PE, Yallop D, Benjamin R, Graham C, Niblock A, Sanderson R.

Front Oncol. 2026 Feb 26;16:1759390. doi: 10.3389/fonc.2026.1759390. eCollection 2026.

Bridging the gap: Evaluating a community-based palliative care intervention for underserved patients with Parkinson's disease

Yilmaz S, Aslam S, Sillau S, Katz M, Kluger B.

Parkinsonism Relat Disord. 2026 May;146:108262. doi: 10.1016/j.parkreldis.2026.108262. Epub 2026 Mar 6.

Sex differences in the severity of non-motor symptoms in Parkinson's disease: a systematic review and meta-analysis

Cicero CE, Terravecchia C, Pettinato LL, Tabbì S, Donzuso G, Contrafatto D, Mostile G, Zappia M, Nicoletti A.

NPJ Parkinsons Dis. 2026 Mar 18;12(1):112. doi: 10.1038/s41531-026-01323-w.

Massive-scale single-nucleus multi-omics identifies novel rare noncoding drivers of Parkinson's disease

Menon S, Turner AW, Chang SH, Johnson AW, Chang HH, Shah AJ, Zeng Y, Strohlein CE, Kampman L, Colston C, Kozlenkov A, Dracheva S, Avenali M, Palermo G, Ceravolo R, Valente EM, Gabbert C, Trinh J, Serrano GE, Beach TG; Global Parkinson’s Genetic Program (GP2); Shulman JM, Blauwendraat C, Montine TJ, Fang ZH, Belloy ME, Corces MR.

bioRxiv [Preprint]. 2026 Mar 5:2026.03.05.709922. doi: 10.64898/2026.03.05.709922.

Re-Emergent Postural Tremor Without Clinical Resting Tremor in Parkinson's Disease-A Case Report

van den Berg KRE, Helmich RC.

Mov Disord Clin Pract. 2026 Oct;13(10):2610-2613. doi: 10.1002/mdc3.70690. Epub 2026 May 24.

Modeling cis-regulatory variation in human brain enhancers across a large Parkinson's Disease cohort

Sigalova OM, Pančíková A, De Man J, Theunis K, Hulselmans GJ, Konstantakos V, Stuyven B, De Brabandere A, Geurts J, Mikorska A, Mukherjee S, Abouelasrar Salama S, Vandereyken K, Davie K, Mahieu L, Adler CH, Beach TG, Serrano GE, Voet T, Demeulemeester J, Aerts S.

bioRxiv [Preprint]. 2026 Apr 16:2026.03.15.711881. doi: 10.64898/2026.03.15.711881.

Brain-Only Versus GI-Only Synucleinopathy: A Comprehensive Autopsy Study With Both IHC and SAA

Orru CD, Beach TG, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Atri A, Lorenzini I, Qiji SH, Intorcia AJ, Hughson AG, Groveman BR, King S, Alam P, Parveen S, Vascellari S, Caughey B, Serrano GE.

medRxiv [Preprint]. 2026 Mar 24:2026.03.18.26348355. doi: 10.64898/2026.03.18.26348355.

Synthetic strategies for small molecule compounds for the treatment of Parkinson's disease: targeting α-synuclein

Ai B, Zhang XY, Hu CY, Guo Z, Jin CH.

Mol Divers. 2026 Mar 12. doi: 10.1007/s11030-026-11510-9. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias